Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review

• J. Bryant,
• A. Clegg,
• T. Nicholson,
• L. McIntyre,
• S. De Broe,
• K. Gerard,
• N. Waugh

Affiliations

J. Bryant

Wessex Institute for Health Research and Development, University of Southampton, UK

A. Clegg

Wessex Institute for Health Research and Development, University of Southampton, UK

T. Nicholson

Wessex Institute for Health Research and Development, University of Southampton, UK

L. McIntyre

Wessex Institute for Health Research and Development, University of Southampton, UK

S. De Broe

Wessex Institute for Health Research and Development, University of Southampton, UK

K. Gerard

Wessex Institute for Health Research and Development, University of Southampton, UK

N. Waugh

Wessex Institute for Health Research and Development, University of Southampton, UK